New Ovarian Cancer Drug Approved in England Offers Extended Life
A new life-prolonging drug for advanced ovarian cancer has been approved for use in England. This breakthrough treatment is expected to offer patients more time and an improved quality of life.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
Breakthrough ovarian cancer drug offers patients more time and better quality of life
Women taking the drug tell the BBC it has given them their lives back.
Read full article →Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant ovarian cancer to be approved for more than 20 years. Ovarian is the 18th most common type of cancer globally, affecting more than 300,000 women a year. More than three-quarters of patients are diagnosed at...
By Anna Bawden Health and social affairs correspondent
Read full article →
